Operating Expenses Cambiamento Data
Acadia Pharmaceuticals USD 196.1M 73.38M 2023-12
Adma Biologics USD 85.84M 27.26M 2023-12
ALKERMES USD 337.09M 41.11M 2023-09
Alterity Therapeutics Limited AUD 7.78M 3M 2023-06
AstraZeneca USD 9.54B 578M 2023-09
BioCryst Pharmaceuticals USD 98.66M 33.55M 2023-09
Bristol-Myers Squibb USD 9.62B 984M 2023-12
Cipla INR 52.34B 1.6B 2023-09
Clal Biotechnology ILS 5.15M 9.47M 2022-12
Compugen USD 10.63M 414K 2023-09
CSL USD 5.19B 142.6M 2023-06
Dynavax Technologies USD 64.09M 311K 2023-12
Eli Lilly USD 6.97B 2.08B 2023-12
Esperion Therapeutics USD 61.5M 1.34M 2023-09
GlaxoSmithKline GBP 6.2B 1.16B 2023-09
Grifols EUR 1.35B 73.17M 2023-09
Halozyme Therapeutics USD 129M 1.25M 2023-12
Ionis Pharmaceuticals USD 303.83M 14.26M 2023-12
J&J USD 16.57B 435M 2023-12
Marinus Pharmaceuticals USD 38.98M 1.46M 2023-09
Merck USD 16.56B 6.35B 2023-12
Minerva Neurosciences USD 6.08M 1.56M 2023-09
Neurocrine Biosciences USD 357.6M 21.5M 2023-09
Novavax USD 312.62M 56.35M 2023-09
Pfizer USD 20.8B 4.62B 2023-12
Roche Holding CHF 20.02B 5.04B 2023-06
Takeda JPY 1.09T 202.38B 2023-09
Vanda Pharmaceuticals USD 48.92M 11.57M 2023-06



Minerva Neurosciences Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2024.